tetano
Editor, Senior Moderator
Clin Case Rep
. 2020 Sep 25;10.1002/ccr3.3358.
doi: 10.1002/ccr3.3358. Online ahead of print.
Severe coronavirus disease 2019 (COVID-19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
Hayato Koba[SUP] 1 2 [/SUP], Taro Yoneda[SUP] 1 2 [/SUP], Tomoya Kaneda[SUP] 3 [/SUP], Tsukasa Ueda[SUP] 1 [/SUP], Hideharu Kimura[SUP] 4 [/SUP], Kazuo Kasahara[SUP] 4 [/SUP]
Affiliations
Abstract
The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical practice.
Keywords: COVID‐19; Lopinavir; favipiravir; ferritin; lymphocytopenia; ritonavir.
. 2020 Sep 25;10.1002/ccr3.3358.
doi: 10.1002/ccr3.3358. Online ahead of print.
Severe coronavirus disease 2019 (COVID-19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
Hayato Koba[SUP] 1 2 [/SUP], Taro Yoneda[SUP] 1 2 [/SUP], Tomoya Kaneda[SUP] 3 [/SUP], Tsukasa Ueda[SUP] 1 [/SUP], Hideharu Kimura[SUP] 4 [/SUP], Kazuo Kasahara[SUP] 4 [/SUP]
Affiliations
- PMID: 33042544
- PMCID: PMC7537071
- DOI: 10.1002/ccr3.3358
Abstract
The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19. Serum ferritin levels and lymphocytopenia are promising markers for disease severity and disease progression that are commonly available in general clinical practice.
Keywords: COVID‐19; Lopinavir; favipiravir; ferritin; lymphocytopenia; ritonavir.